2020 has proven to be a fairly turbulent year for consumer health in Germany following the emergence of the pandemic. After the ‘’hamster’’ (stockpiling purchases) period in March due to various lockdown restrictions by the government in an effort to curb the spread of the virus, it was followed by a slump, with the market subsequently entering...
With Kenyans mired in the COVID-19 pandemic, it is perhaps not surprising that value sales of consumer health products are set to rise in 2020 at a rate higher than those recorded during the review period. Broadly, a pandemic-inspired heightened focus on maintaining/improving health is driving greater interest in over the counter (OTC) health...
Consumer health value sales will continue to grow in 2020, despite the negative economic impact of COVID-19 on the economy. Lower purchasing power among middle-income consumers and the rising cost of healthcare in Argentina have fuelled a shift towards self-medication in recent years, thus encouraging preventive healthcare. Following this...
The Malaysian Government implemented the Movement Control Order (MCO) from 18 March to 4 May in an effort to contain the spread of the COVID-19 pandemic in the country. There followed the Conditional Movement Control Order (CMCO) – between 4 May and 10 June, and the Recovery Movement Control Order (RMCO) – between 10 June and 31 August. All...
Overall, consumer health is expected to perform well, due to increased demand as a result of COVID-19, with most areas product areas expected to register double-digit current value growth. Though 2020 current value growth is not expected to be as high as in 2019, a lot of the growth over the review period was driven by inflation rather than...
The outbreak and development of Coronavirus (COVID-19) from early March 2020 halted the economic improvement in the country. Lockdown and other restrictions on business, education and cultural institutions and the population in general fed into rising unemployment, wage cuts and reduced disposable incomes as the government tried to contain...
The outbreak of COVID-19 in South Korea is not predicted to increase growth in 2020, with value growth of 3% expected for the year, compared to value growth of 5% recorded in 2019. As South Korea did not have an enforced lockdown, sales were not impacted by high levels of stockpiling that was seen in other countries Consumer Health...
The outbreak of Coronavirus (COVID-19) has provided a shock to both the Spanish economy and society and significantly impacted consumer health sales. While Spain has not suffered from obvious shortages of medicines, the stockpiling of certain products, especially analgesics and cough, cold and allergy (hay fever) remedies, has been observed. Consumer...
To mitigate the risk of contracting COVID-19 consumers in Japan have been confining themselves to their homes on a more regular basis, while they are also taking a more proactive approach to their health, focusing on prevention over treatment. This has resulted in contrasting fortunes for the various product categories within consumer health....
The outbreak of COVID-19 is not expected to increase growth in 2020, with value growth of 2% predicted for the year, compared to value growth of 4% recorded in 2019. Unlike other countries, Sweden did not go into a full lockdown during Q1 and Q2, and this had some impact on the level of stockpiling that took place, which was mainly seen in...